伪狂犬病毒R2非嗜神经疫苗:猪概念验证研究
本研究在猪模型中评估源于α-疱疹病毒伪狂犬病毒(PRV)的R2疫苗特性与效力。结果显示R2疫苗在检测限内不侵入猪外周神经系统,且单次鼻内接种后对强毒PRV野毒株(NIA-3)攻击提供保护。表明R2疫苗设计具非嗜神经性,在自然宿主中有效。
要点
- R2疫苗在猪检测限内不侵入外周神经系统。
- 单次鼻内接种R2可保护猪抵抗强毒PRV NIA-3攻击。
- R2疫苗设计在自然宿主中具非嗜神经性与有效性。
核心结论
- PRV R2疫苗在猪中不侵入外周神经系统且单次鼻内接种可抵抗强毒PRV攻击。
研究设计与样本
- 在猪中评估源于α-疱疹病毒PRV的R2疫苗特性与效力的概念验证研究。
主要发现
- R2疫苗在检测限内不侵入猪外周神经系统。
- 单次鼻内接种后R2对强毒PRV野毒株NIA-3攻击提供保护。
临床怎么用
- 支持R2疫苗设计作为非嗜神经且有效的疫苗策略在自然宿主中应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neurotropic alpha-herpesviruses that infect mammals establish life-long latent infections in the peripheral nervous system after initial infection of exposed mucosal tissues. The neuroinvasive properties can lead to severe complications both with clinical and veterinary alpha-herpesviruses, and vaccines are often unavailable or provide limited protection. Here we assess the properties and efficacy of an R2 vaccine derived from the alpha-herpesvirus, pseudorabies virus (PRV), in pigs. We demonstrate that the PRV R2 vaccine does not invade the porcine peripheral nervous system within the limits of detection. Furthermore, after a single intranasal vaccination, R2 conferred protection to pigs subsequently challenged with a virulent PRV field strain (NIA-3). These findings support that the R2 vaccine design is non-neuroinvasive and is an effective vaccine in the context of a natural host.
引用
- Pickard GE, Brodersen B, Sollars PJ, et al. The pseudorabies virus R2 non-neuroinvasive vaccine: A proof-of-concept study in pigs. Vaccine. 2020. PMID: 32448623. doi:10.1016/j.vaccine.2020.05.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。